Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Chronic Myelogenous Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myelogenous Leukemia
  • B Cell Lymphoma
  • Burkitt's Lymphoma
  • Small Lymphocytic Lymphoma
  • Myeloproliferative Syndromes
  • Chronic Lymphocytic Leukemia
  • Myelodysplastic Syndromes
  • Follicular Lymphoma
  • Hematological Diseases
  • Non Hodgkin's Lymphoma
  • Multiple Myeloma
  • Plasma Cell Leukemia
  • Lymphoblastic Lymphoma
  • Lymphoplasmacytic Lymphoma
  • Mantle Cell Lymphoma
  • Prolymphocytic Leukemia
Type
Interventional
Phase
Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Younger than 75 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02661035
Collaborators
Not Provided
Investigators
Principal Investigator: Erica Warlick, MD Masonic Cancer Center, University of Minnesota